Results for companion therapy translation from Danish to Italian

safety studies for gene therapy products.
safety studies for gene therapy products.

- bill schjelderup, president, companion corporation
- bill schjelderup, presidente, companion corporation

b01ad thrombolytic therapy for acute myocardial infarction
b01ad thrombolytic therapy for acute myocardial infarction

jo5afo6 combination therapy of hiv- 1 infected patients
jo5afo6 combination therapy of hiv-1 infected patients

n03a adjunctive therapy in the partial onset seizures in epilepsy
therapy in the

a16ax03 adjunctive therapy in the chronic management of urea cycle disorders
a16ax03 adjunctive therapy in the chronic management of urea cycle disorders

a) cattle b) adjunctive therapy in acute respiratory infection
a) cattle b) adjunctive therapy in acute respiratory infection

concept paper on the development of a points to consider on xenogeneic cell therapy
points to consider on xenogeneic cell therapy note for guidance on the production and

long- term replacement therapy in patients with a confirmed diagnosis of fabry disease
long-term replacement therapy in patients with a confirmed diagnosis of

a16ax06 ttreatment of mild to moderate type 1 gaucher disease when enzyme replacement therapy is unsuitable
disease when enzyme replacement therapy is unsuitable

punkter, som bør tages i betragtning helicobacter pylori eradication therapy wording in selected spc sections
documento «punti da considerare» helicobacter pylori eradication therapy wording in selected spc sections

single- dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women:
single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women:

boehringer ingelheim l03aa international gmbh adjunct therapy de to surgery for irresectable soft tissue sarcoma of the limbs, to prevent or delay amputation
boehringer ingelheim l03aa international gmbh adjunct therapy de to surgery for irresectable soft tissue sarcoma of the limbs, to prevent or delay amputation

titel på dokumentet antimicrobials for general use in target animal species summary of product characteristics for antimicrobial products efficacy requirements for ectoparasiticides for cattle fluid therapy
titolo del documento antimicrobials for general use in target animal species summary of product characteristics for antimicrobial products efficacy requirements for ectoparasiticides for cattle fluid therapy

der blev ligeledes fundet en reduktion i træthed, målt ved hjælp af ” functional assessment of cancer therapy- fatigue te
È stato inoltre osservato un miglioramento nell’ affaticamento, misurato con la scala functional assessment of cancer therapy – fatigue (fact – fatigue).

need for post- marketing data contribution to cpmp points to consider document on xenogeneic cell therapy proposals for revision to standard operating procedure on urgent safety restrictions for medicinal products authorised through the mutual recognition procedure
need for post-marketing data contribution to cpmp points to consider document on xenogeneic cell therapy proposals for revision to standard operating procedure on urgent safety restrictions for medicinal products authorised through the mutual recognition procedure

mtx; health assessment questionnaire (haq); functional assessment of chronic illness therapy (facit- f)
mtx, questionario di valutazione dello stato di salute (haq), valutazione funzionale della terapia delle malattie croniche (facit-f)

* i følge national cancer institute of canada clinical trial group (ncic ctg) common toxicity criteria (version 1) eller common terminology criteria for adverse events (ctcae) fra cancer therapy evaluation program, us national cancer institute, version 3, 0.
*secondo i criteri comuni di tossicità (versione 1) del national cancer institute of canada clinical trial group (ncic cgt) o i criteri comuni di terminologia per gli eventi avversi (ctcae) del cancer therapy evaluation program, us national cancer institute, versione 3.0.